Wojciech Miltyk - Search Results

Year	Number of Results
2005	3
2006	3
2007	4
2008	3
2009	5
2010	6
2012	1
2013	2
2014	1
2015	5
2016	7
2017	2
2018	7
2019	4
2020	9
2021	9
2022	10
2023	6
2024	2

1

Celecoxib in Cancer Therapy and Prevention - Review.

Tołoczko-Iwaniuk N, Dziemiańczyk-Pakieła D, Nowaszewska BK, Celińska-Janowicz K, Miltyk W. Tołoczko-Iwaniuk N, et al. Among authors: miltyk w. Curr Drug Targets. 2019;20(3):302-315. doi: 10.2174/1389450119666180803121737. Curr Drug Targets. 2019. PMID: 30073924 Review.

2

Proline-containing peptides-New insight and implications: A Review.

Misiura M, Miltyk W. Misiura M, et al. Among authors: miltyk w. Biofactors. 2019 Nov;45(6):857-866. doi: 10.1002/biof.1554. Epub 2019 Aug 20. Biofactors. 2019. PMID: 31430415 Review.

3

New potential biomarkers of acetaminophen-induced hepatotoxicity.

Siemionow K, Teul J, Drągowski P, Pałka J, Miltyk W. Siemionow K, et al. Among authors: miltyk w. Adv Med Sci. 2016 Sep;61(2):325-330. doi: 10.1016/j.advms.2016.05.001. Epub 2016 May 30. Adv Med Sci. 2016. PMID: 27471017 Review.

4

Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests.

Tafazoli A, Guggilla RK, Kamel-Koleti Z, Miltyk W. Tafazoli A, et al. Among authors: miltyk w. Genes (Basel). 2021 Mar 3;12(3):361. doi: 10.3390/genes12030361. Genes (Basel). 2021. PMID: 33802585 Free PMC article. Review.

5

Proline Metabolism in Malignant Gliomas: A Systematic Literature Review.

Sawicka MM, Sawicki K, Łysoń T, Polityńska B, Miltyk W. Sawicka MM, et al. Among authors: miltyk w. Cancers (Basel). 2022 Apr 17;14(8):2030. doi: 10.3390/cancers14082030. Cancers (Basel). 2022. PMID: 35454935 Free PMC article. Review.

6

Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice.

Tafazoli A, Guchelaar HJ, Miltyk W, Kretowski AJ, Swen JJ. Tafazoli A, et al. Among authors: miltyk w. Front Pharmacol. 2021 Aug 25;12:693453. doi: 10.3389/fphar.2021.693453. eCollection 2021. Front Pharmacol. 2021. PMID: 34512329 Free PMC article. Review.

7

Proline Oxidase (POX) as A Target for Cancer Therapy.

Kononczuk J, Czyzewska U, Moczydlowska J, Surażyński A, Palka J, Miltyk W. Kononczuk J, et al. Among authors: miltyk w. Curr Drug Targets. 2015;16(13):1464-9. doi: 10.2174/138945011613151031150637. Curr Drug Targets. 2015. PMID: 26553010 Review.

8

Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs.

Miltyk W, Patrinos GP, Verstuyft C, Coenen M, Tafazoli A. Miltyk W, et al. Front Pharmacol. 2022 Nov 11;13:1053027. doi: 10.3389/fphar.2022.1053027. eCollection 2022. Front Pharmacol. 2022. PMID: 36438788 Free PMC article. No abstract available.

9

Current Understanding of the Emerging Role of Prolidase in Cellular Metabolism.

Misiura M, Miltyk W. Misiura M, et al. Among authors: miltyk w. Int J Mol Sci. 2020 Aug 17;21(16):5906. doi: 10.3390/ijms21165906. Int J Mol Sci. 2020. PMID: 32824561 Free PMC article. Review.

10

New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention.

Kolodziejczyk P, Gromotowicz-Poplawska A, Aleksiejczuk M, Chabielska E, Tutka P, Miltyk W. Kolodziejczyk P, et al. Among authors: miltyk w. Curr Drug Targets. 2018;19(16):1968-1979. doi: 10.2174/1389450119666180326125926. Curr Drug Targets. 2018. PMID: 29577853 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

82 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year